The Results Are In from Quest Diagnostics®
The Results Are In from Quest Diagnostics®
Podcast Description
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
Podcast Insights
Content Themes
The podcast focuses on a variety of topics within the field of diagnostics, such as innovative lab testing techniques, the role of biomarkers in early detection of diseases like Alzheimer’s, and the impact of diagnostic choices on patient care. Episodes highlight case studies, like the integration of blood-based biomarkers for Alzheimer’s risk assessment, underscoring trends that shape healthcare delivery.
Physicians routinely diagnose and treat acute and chronic conditions
across multiple clinical areas. Whether it’s a condition studied for
decades or an emerging infection, comprehensive diagnostic testing is
enabling faster and more effective care to drive better patient outcomes.
In fact, most medical decisions are based at least partly on lab testing!
On The Results Are In from Quest Diagnostics®, we are joined by
diagnostics industry leaders who support providers in optimizing care
pathways for their patients. From the latest in cutting-edge research to
the real-world impact of diagnostic testing on treatment journeys, The
Results Are In features can’t-miss stories for those wanting to stay in the
know about the latest innovations in laboratory diagnostics.
In this episode of Results are In by Quest Diagnostics, Dr. Jack Kain joins Jason Suomala to explain the threat of novel psychoactive substances and how Quest’s updated testing panel helps providers identify what’s being used and treat patients with more confidence.
They break down what providers need to know about NPS classes like designer benzodiazepines, fentanyl analogs, synthetic cannabinoids, and more. With real-world case studies and clinical insights, the discussion highlights why traditional drug testing often misses these compounds—and how Quest’s updated NPS panel helps providers detect risk and guide treatment with greater accuracy.
The episode also explores how the evolving drug landscape, fueled by counterfeit pills and illicit drug mixing, is increasing overdose risks across the country. Whether you’re a healthcare professional, toxicologist, or public health advocate, this conversation will help you better understand what’s really showing up in patients’ systems and what to do about it.
Follow Us
Twitter @QuestDX
Facebook @QuestDiagnostics
Instagram @QuestDiagnostics
LinkedIn @QuestDiagnostics
Presented by Quest Diagnostics
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.